ResearcherCzech Academy of Sciences, Institute of BiotechnologyNo recent work listed
Zuzana Nahácka
Matched on ORCID iD 0000-0003-0477-2764; OpenAlex author ID A5010579301. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 2
- SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. First author DOI 10.1038/s41388-021-01726-4↗
- TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor. Co-author DOI 10.1016/j.bbamcr.2017.12.006↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiřı́ Neužil · 2 shared papers, 2018–2021 · strength 0.21
- Paper SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. DOI 10.1038/s41388-021-01726-4↗
- Paper TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/D… DOI 10.1016/j.bbamcr.2017.12.006↗
- Zuzana Ezrova · 1 shared paper, 2021 · strength 0.12
- Štěpána Boukalová · 1 shared paper, 2021 · strength 0.12
- Ladislav Anděra · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.